Invention Grant
- Patent Title: Thiadiazole IRAK4 inhibitors
-
Application No.: US17204463Application Date: 2021-03-17
-
Publication No.: US11702414B2Publication Date: 2023-07-18
- Inventor: Stephen Ammann , Elizabeth M. Bacon , Gediminas Brizgys , Elbert Chin , Chienhung Chou , Jeromy J. Cottell , Marilyn Ndukwe , Marina Shatskikh , James G. Taylor , Nathan E. Wright , Zheng-Yu Yang , Sheila M. Zipfel
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04
Abstract:
A compound of Formula (I):
pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.
pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.
Public/Granted literature
- US20220402910A1 THIADIAZOLE IRAK4 INHIBITORS Public/Granted day:2022-12-22
Information query
